http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040105816-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate | 2003-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2004-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20040105816-A |
titleOfInvention | 1-n-aminobenzimidazole derivatives |
abstract | Formula (I)n n n n n n n n (Wherein, R 1 , R 2 are alkyl groups which may have a substituent, R 3 , R 5 , R 6 are alkyl groups, alkoxy groups, hydrogen atoms, etc., and R 4 is alkyl groups which may have substituents, etc. A The benzene ring etc., B represents an oxygen atom, etc., n represents the integer of 0-2.) The 1-N-aminobenzimidazole derivative or its salt, and the pharmaceutical containing it are provided.n n n Since the compound (I) of the present invention has a small individual difference in the therapeutic effect due to individual differences in CYP2C19 activity, an appropriate therapeutic effect can be obtained at the same dose in any patient, and the interaction and cancer induced by CYPIA family induction It is useful as a peptic ulcer therapeutic agent that obtains a safe and reliable therapeutic effect because of low risk of induction. |
priorityDate | 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 468.